Patents by Inventor Bee C. Ding

Bee C. Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20200208132
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: August 9, 2019
    Publication date: July 2, 2020
    Applicant: PROTEON THERAPEUTICS, INC.
    Inventors: F. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • Nucleic acid molecules encoding autoactivating type I pancreatic proelastase proteins
    Patent number: 10308924
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: June 4, 2019
    Assignee: PROTEON THERAPEUTICS, INC.
    Inventors: F. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • Recombinant elastase proteins and methods of manufacturing and use thereof
    Patent number: 10301612
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: May 28, 2019
    Assignee: PROTEON THERAPEUTICS, INC.
    Inventors: F. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20190062718
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: March 13, 2018
    Publication date: February 28, 2019
    Applicant: Proteon Therapeutics, Inc.
    Inventors: F. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • Recombinant Elastase Proteins and Methods of Manufacturing and Use Thereof
    Publication number: 20190010476
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: January 12, 2018
    Publication date: January 10, 2019
    Applicant: Proteon Therapeutics, Inc.
    Inventors: F. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20180273928
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: October 6, 2017
    Publication date: September 27, 2018
    Applicant: Proteon Therapeutics, Inc.
    Inventors: F. Nicholas FRANANO, Kimberly S. Bland, Marco D. Wong, Bee C. Ding
  • NUCLEIC ACID MOLECULES ENCODING AUTOACTIVATING TYPE I PANCREATIC PROELASTASE PROTEINS
    Publication number: 20180208918
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: March 13, 2018
    Publication date: July 26, 2018
    Applicant: Proteon Therapeutics, Inc.
    Inventors: F. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20180155703
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: January 25, 2018
    Publication date: June 7, 2018
    Applicant: Proteon Therapeutics, Inc.
    Inventors: F. Nicholas FRANANO, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20160319267
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: May 4, 2016
    Publication date: November 3, 2016
    Applicant: Proteon Therapeutics, Inc.
    Inventors: F. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20160243205
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: December 3, 2015
    Publication date: August 25, 2016
    Applicant: Proteon Therapeutics, Inc.
    Inventors: F. Nicholas FRANANO, Kimberly S. Bland, Marco D. Wong, Bee C. Ding
  • Recombinant Elastase Proteins and Methods of Manufacturing and Use Thereof
    Publication number: 20150329846
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: May 19, 2015
    Publication date: November 19, 2015
    Applicant: PROTEON THERAPEUTICS, INC.
    Inventors: F. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20150322420
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: June 24, 2010
    Publication date: November 12, 2015
    Inventors: F. NICHOLAS FRANANO, KIMBERLY S. BLAND, MARCO D. WONG, BEE C. DING
  • Recombinant Elastase Proteins and Methods of Manufacturing and Use Thereof
    Publication number: 20150166974
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: August 21, 2014
    Publication date: June 18, 2015
    Applicant: PROTEON THERAPEUTICS, INC.
    Inventors: F. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • Recombinant elastase proteins and methods of manufacturing and use thereof
    Patent number: 9057060
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Grant
    Filed: December 4, 2008
    Date of Patent: June 16, 2015
    Assignee: Proteon Therapeutics, Inc.
    Inventors: F. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20130336956
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: August 2, 2013
    Publication date: December 19, 2013
    Applicant: Proteon Therapeutics, Inc.
    Inventors: F. Nicholas Franano, Kimberly S. Bland, Marco D. Wong, Bee C. Ding
  • Recombinant elastase proteins and methods of manufacturing and use thereof
    Patent number: 8501449
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Grant
    Filed: December 3, 2008
    Date of Patent: August 6, 2013
    Assignee: Proteon Therapeutics, Inc.
    Inventors: F. Nicholas Franano, Kimberly S. Bland, Marco D. Wong, Bee C. Ding
  • RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20110081705
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: June 24, 2010
    Publication date: April 7, 2011
    Inventors: F. NICHOLAS FRANANO, KIMBERLY S. BLAND, MARCO D. WONG, BEE C. DING
  • RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20110008315
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: December 4, 2008
    Publication date: January 13, 2011
    Inventors: F. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
  • RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20090162343
    Abstract: The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
    Type: Application
    Filed: December 3, 2008
    Publication date: June 25, 2009
    Inventors: F. Nicholas Franano, Kimberly S. Bland, Marco D. Wong, Bee C. Ding